Abstract:Inflammatory bowel disease (IBD) is a chronic and relapsing intestinal inflammatory condition with no effective treatment. Probiotics have gained wide attention because of their outstanding advantages in intestinal health issues. In previous studies, a novel soluble protein, HM0539, which is derived from <i>Lactobacillus rhamnosus</i> GG (LGG), showed significant protective effects against murine colitis, but no clear precise mechanism for this effect was provided. In this study, we hypothesized that the protective function of HM0539 might be derived from its modulation of the TLR4/Myd88/NF-κB axis signaling pathway, which is a critical pathway widely involved in the modulation of inflammatory responses. To test this hypothesis, the underlying anti-inflammatory effects and associated mechanisms of HM0539 were determined both in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages and in dextran sulfate sodium (DSS)-induced murine colitis. Our results showed that HM0539 inhibited the expression of cyclooxygenase-2 (COX-2) and the expression inducible nitric oxide synthase (iNOS) by down-regulating the activation of their respective promoter, and as a result this inhibited the production of prostaglandin E2 (PGE2) and nitric oxide (NO). Meanwhile, we demonstrated that HM0539 could ultimately modulate the activation of distal NF-κB by reducing the activation of TLR4 and suppressing the transduction of MyD88. However, even though the overexpression of TLR4 or MyD88 obviously reversed the effect of HM0539 on LPS-induced inflammation, HM0539 still retained some anti-inflammatory activity. Consistent with the <i>in vitro</i> findings, we found that HM0539 inhibited to a great extent the production of inflammatory mediators associated with the suppression of the TLR4/Myd88/NF-κB axis activation in colon tissue. In conclusion, HM0539 was shown to be a promising anti-inflammatory agent, at least in part through its down-regulation of the TLR4-MyD88 axis as well as of the downstream MyD88-dependent activated NF-κB signaling, and hence might be considered as a potential therapeutic option for IBD.

Anti-inflammation and adhesion enhancement properties of the multifunctional LPxTG-motif surface protein derived from the <i>Lactobacillus reuteri</i> DSM 8533

Anti-inflammation and adhesion enhancement properties of the multifunctional LPxTG-motif surface protein derived from the Lactobacillus reuteri DSM 8533

Retracted: Multifunctional LPxTG‐motif Surface Protein Derived from Limosilactobacillus Reuterish 23 in DSS‐induced Ulcerative Colitis of Mice

Gastrointestinal Tolerance Enhancement of the LPxTG-motif Surface Protein Overexpressed Lactobacillus Reuteri SH23 in Vivo

Multifunctional properties of the transmembrane LPxTG-motif protein derived from Limosilactobacillus reuteri SH-23

New Lactobacillus plantarum membrane proteins (LpMPs) towards oral anti-inflammatory agents against dextran sulfate sodium-induced colitis

Protective effects of a novel Lactobacillus rhamnosus strain with probiotic characteristics against lipopolysaccharide-induced intestinal inflammation in vitro and in vivo.

iTRAQ proteomic analysis of N-acetylmuramic acid mediated anti-inflammatory capacity in LPS-induced RAW 264.7 cells.

Peptidoglycan Diversity and Anti-Inflammatory Capacity in Lactobacillus Strains.

Inhibitory Effects of the Lactobacillus rhamnosus GG Effector Protein HM0539 on Inflammatory Response Through the TLR4/MyD88/NF-кB Axis

Doses Lactobacillus Reuteri Depend on Adhesive Ability to Modulate the Intestinal Immune Response and Metabolism in Mice Challenged with Lipopolysaccharide

A Novel Strategy for Designing the Antioxidant and Adhesive Bifunctional Protein Using the Lactobacillus Strain-Derived LPxTG Motif Structure

Coupled Effect of Nutritional Food Molecules and Lactobacillus Reuteri Surface Protein Interaction on the Bacterial Gastrointestinal Tolerance

Newly Isolated Limosilactobacillus reuteri B1/1 Modulates the Expression of Cytokines and Antimicrobial Proteins in a Porcine ex Vivo Model

Purification of Lactobacillus Acidophilus Surface-Layer Protein and Its Immunomodulatory Effects on RAW264.7 Cells.

Adhesion Characteristics and Dual Transcriptomic and Proteomic Analysis of Lactobacillus Reuteri SH23 Upon Gastrointestinal Fluid Stress

Potential role of a series of lysine-/leucine-rich antimicrobial peptide in inhibiting lipopolysaccharide-induced inflammation.

Structure and immunomodulatory activity of a recombinant mucus-binding protein of Lactobacillus acidophilus.

Whole genome sequencing analysis of Limosilactobacillus reuteri from the intestinal tract of mice recovering from ulcerative colitis and preliminary study on anti-inflammatory effects of its derived peptides

Determination of the regulatory network and function of the lysR-type transcriptional regulator of Lactiplantibacillus plantarum, LpLttR

Mutual Adhesion of Lactobacillus Spp. to Intestinal Cells: A Review of Perspectives on Surface Layer Proteins and Cell Surface Receptors